Windtree Therapeutics Inc Share Price

NASDAQ: WINT

$0.06

-0.08

(-55.35%)

as on September 13, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 21 Aug 2025

Windtree Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$0.13
Day's Price Range
$0.18
$0.06
-116.67%
Downside
200.00%
Upside
52 Week's Low
52 Week's High
$0.09
52-Week Price Range
$178
$0.06
-50.00%
Downside
296566.67%
Upside

Windtree Therapeutics Inc share price movements today

Previous Close: $0.14
Open: $0.15
Volume: 6.1M
Day's Low - High: $0.13 - $0.18
52 Week Low - High: $0.09 - $178

Windtree Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Windtree Therapeutics Inc Stock Fundamentals & Key Indicators

Check Windtree Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Windtree Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Windtree Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Windtree Therapeutics Inc	SELL	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Analyst Recommendation on Windtree Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Windtree Therapeutics Inc. Average target price of $4

Windtree Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Windtree Therapeutics Inc.

What analysts predicted

98.5%UPSIDE

Target Price

Current Price

$0.06

Analyzed by

6 Analysts

Target

$4.00

Windtree Therapeutics Inc target price $4, a slight upside of 98.5% compared to current price of $0.06. According to 6 analysts rating.

Windtree Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	-	-	-	-	-	-	-	-	0
Gross Profit	0	0	0	0	0	0	0	-	0
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-4	-6	-4	-5	10	-12	-2	2	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-4494.44%

Windtree Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	2	1	1	0	-	-	-	-	-
Gross Profit	0	1	-15	-8	0	0	0	-1	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-55	-39	-18	-20	-29	-30	-67	-39	-20	-5
Net Profit Margin	-5589.67%	-1933.89%	-1242.15%	-1148.38%	-15081.82%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Windtree Therapeutics Inc

Funds	Holdings
UBS Group AG	0.79%
Morgan Stanley - Brokerage Accounts	0.41%
Tower Research Capital LLC	0.04%
Bank of America Corp	0%
SBI Securities Co Ltd	0%

See all

Insights on Windtree Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 114.2% return, outperforming this stock by 214.2%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 168.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, WINT stock has moved down by -78.5%

About Windtree Therapeutics Inc

Windtree Therapeutics, Inc. is a diversified company. The Company is engaged in the biotechnology business, advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure and preclinical precision aPKCi inhibitors that are being developed for potential in rare and broad oncology applications. Istaroxime is a first-in-class dual-mechanism therapy designed to improve both systolic and diastolic cardiac function. aPKCi inhibitor platform is a potential high-potency, specific, drug candidate with applications in oncology, particularly in hedgehog pathway-dependent cancers. The Company also has a licensing business model with partnership out-licenses in place. The Company is also focused on environmental services space.

Organisation	Windtree Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Windtree Therapeutics Inc share price today?

Windtree Therapeutics Inc share price today is $0.06 as on September 13, 2025 at 1:29 am IST at the close of the market. Windtree Therapeutics Inc share today touched a day high of $0.18 and a low of $0.13.

What is the 52 week high and 52 week low for Windtree Therapeutics Inc share?

Windtree Therapeutics Inc share touched a 52 week high of $178 on September 13, 2024 and a 52 week low of $0.09 on August 21, 2025. Windtree Therapeutics Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $0.06,which is 99.97% down from its 52 week high and -33.33% up from its 52 week low.

How to invest in Windtree Therapeutics Inc Stock (WINT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Windtree Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Windtree Therapeutics Inc Shares that will get you 25.0000 shares as per Windtree Therapeutics Inc share price of $0.06 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Windtree Therapeutics Inc Stock (WINT) from India?

Indian investors can start investing in Windtree Therapeutics Inc (WINT) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 8:10 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Windtree Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 8:10 pm IST). Based on Windtree Therapeutics Inc share’s latest price of $0.06 as on September 13, 2025 at 1:29 am IST, you will get 166.6667 shares of Windtree Therapeutics Inc. Learn more about fractional shares .